Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer

Clinical trial NCT04132505 · COMPLETED

Trial details

NCT number: NCT04132505
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma Stage IV Pancreatic Cancer AJCC v8

Start date: 2019-10-22
Primary completion: 2026-03-24
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.